Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
INTEGRIS Pharma is a Greek pharmaceutical company specializing in the importation, distribution, and commercialization of innovative therapeutics for rare, chronic, and life-threatening diseases. The company’s portfolio includes orphan drugs for rare/ultra-orphan indications as well as generics and medical devices. It operates primarily in Greece and Cyprus with a mission to ensure patient access to advanced therapies.[1][2][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on INTEGRIS Pharma.